ES2177059T3 - Nuevo cristal de derivado de depsipetido y procedimiento de produccion. - Google Patents

Nuevo cristal de derivado de depsipetido y procedimiento de produccion.

Info

Publication number
ES2177059T3
ES2177059T3 ES98947965T ES98947965T ES2177059T3 ES 2177059 T3 ES2177059 T3 ES 2177059T3 ES 98947965 T ES98947965 T ES 98947965T ES 98947965 T ES98947965 T ES 98947965T ES 2177059 T3 ES2177059 T3 ES 2177059T3
Authority
ES
Spain
Prior art keywords
derivative
depsipetide
production procedure
new crystal
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98947965T
Other languages
English (en)
Inventor
Atsushi Yamamura
Ryo Yamanishi
Muneharu Ikushima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2177059T3 publication Critical patent/ES2177059T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Developing Agents For Electrophotography (AREA)

Abstract

Un cristal (I) de derivado de depsipéptido (IV) representado por la siguiente fórmula: **(Fórmula)** caracterizado porque dicho cristal (I) tiene sustancialmente las propiedades características de difracción de rayos X en polvo descritas en la Tabla 1 y tiene un pico endotérmico sustancialmente a 155°C determinado mediante análisis térmico diferencial.
ES98947965T 1997-11-10 1998-10-20 Nuevo cristal de derivado de depsipetido y procedimiento de produccion. Expired - Lifetime ES2177059T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30753597 1997-11-10

Publications (1)

Publication Number Publication Date
ES2177059T3 true ES2177059T3 (es) 2002-12-01

Family

ID=17970271

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98947965T Expired - Lifetime ES2177059T3 (es) 1997-11-10 1998-10-20 Nuevo cristal de derivado de depsipetido y procedimiento de produccion.

Country Status (18)

Country Link
US (1) US6346603B1 (es)
EP (1) EP1031565B1 (es)
KR (1) KR100551651B1 (es)
CN (1) CN1125057C (es)
AR (1) AR017575A1 (es)
AT (1) ATE221055T1 (es)
AU (1) AU755709B2 (es)
BR (1) BR9815292A (es)
CA (1) CA2308067C (es)
DE (1) DE69806800T2 (es)
DK (1) DK1031565T3 (es)
ES (1) ES2177059T3 (es)
HK (1) HK1035530A1 (es)
NZ (1) NZ504812A (es)
PT (1) PT1031565E (es)
TW (1) TWI225052B (es)
WO (1) WO1999024412A1 (es)
ZA (1) ZA989780B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
JP2008520682A (ja) * 2004-11-17 2008-06-19 ザ ユニヴァーシティー オヴ シカゴ ヒストンデアセチラーゼ阻害剤およびその使用方法
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001953A1 (en) * 1991-07-16 1993-02-04 Gregory William Boland Article retrieval system and vehicle surveillance system
WO1993019053A1 (fr) 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Derive de depsipeptide, production et utilisation
CN1073560C (zh) * 1993-02-19 2001-10-24 明治制果株式会社 环缩酚酸肽pf1022衍生物
ES2170101T3 (es) 1993-09-06 2002-08-01 Fujisawa Pharmaceutical Co Compuesto ciclodepsipeptido.
CN1162409C (zh) 1995-06-30 2004-08-18 藤泽药品工业株式会社 缩肽衍生物、其新型中间体以及中间体的制造方法
WO1998015523A1 (fr) * 1996-10-07 1998-04-16 Fujisawa Pharmaceutical Co., Ltd. Procede de production de derives de depsideptides et leurs nouveaux intermediaires

Also Published As

Publication number Publication date
HK1035530A1 (en) 2001-11-30
CN1125057C (zh) 2003-10-22
NZ504812A (en) 2002-08-28
PT1031565E (pt) 2002-12-31
CA2308067A1 (en) 1999-05-20
ZA989780B (en) 1999-04-28
DK1031565T3 (da) 2002-11-11
CA2308067C (en) 2008-01-08
KR20010031905A (ko) 2001-04-16
DE69806800D1 (de) 2002-08-29
KR100551651B1 (ko) 2006-02-13
ATE221055T1 (de) 2002-08-15
TWI225052B (en) 2004-12-11
AU9464498A (en) 1999-05-31
WO1999024412A1 (fr) 1999-05-20
EP1031565A4 (en) 2001-01-31
US6346603B1 (en) 2002-02-12
EP1031565B1 (en) 2002-07-24
AU755709B2 (en) 2002-12-19
BR9815292A (pt) 2000-10-24
AR017575A1 (es) 2001-09-12
DE69806800T2 (de) 2002-12-05
EP1031565A1 (en) 2000-08-30
CN1285826A (zh) 2001-02-28

Similar Documents

Publication Publication Date Title
CA2093798A1 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
GEP20074251B (en) N-oxycarbonyl substituted 5'- deoxy-5-fluorocytidines
IL111077A (en) Pyridine derivatives processes for the preparation thereof and pharmaceutical compositions containing them
MX9709240A (es) Fenilpiridazinonas.
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
NO962286D0 (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
MY119042A (en) Dolastatin derivatives, their preparation and use
HUP9701265A2 (hu) Imidazolinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítények
HUT54119A (en) Process for producing antiinflammatory aminophenol derivatives
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
NZ300942A (en) 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
ES2177059T3 (es) Nuevo cristal de derivado de depsipetido y procedimiento de produccion.
DE59410304D1 (de) N-substituierte azabicycloheptan-derivate und ihre verwendung, z.b., als neuroleptika
TW369529B (en) 5-heterocyclo-1,5-benzodiazepine derivatives, pharmaceutical composition comprising the same and process for the preparation thereof
HUT61971A (en) Process for producing new derivative of beta-phenylisoserine
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
TR200100475T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
CA2165836A1 (fr) Utilisation des derives du rosmanol pour la fabrication des medicaments anti-radicalaires et/ou antilipoperoxydantes et/ou hepatotropes
ES2101531T3 (es) Derivados de benzo(f)quinoxalinadiona, su preparacion y su utilizacion en medicamentos.
MX9605208A (es) Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
MX9605143A (es) Heterociclibenzonitrilos.